Icon

LANREOTIDE ACETATE (nda215395)- (EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML),EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML),EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML))

LANREOTIDE ACETATE INVAGEN PHARMS
EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML),EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML),EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
No Yes
Expired Expired
None None
None No
Lanreotide Injection is a somatostatin analog indicated for: • The long-term treatment of acromegalic patients who have had an inadequate response to or cannot be treated with surgery and/or radiotherapy. • The treatment of adult patients with unresectable, well-or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to improve progression-free survival.
0 0 0
Total Other Developers 5
Drugs with Suitability No
EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML) ** ** - - -
EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML) ** ** - - -
EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.